Publication Name	World Journal of Stem Cells
Manuscript ID	103100
Country	Italy

Received	2024-11-08 08:26
Peer-Review Started	2024-11-08 08:26
To Make the First Decision
Return for Revision	2025-02-10 08:43
Revised	2025-02-17 12:52
Second Decision	2025-04-15 02:44
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-04-16 10:57
Articles in Press	2025-04-16 10:57
Publication Fee Transferred
Edit the Manuscript by Language Editor	2025-05-06 04:46
Typeset the Manuscript	2025-05-19 03:51
Publish the Manuscript Online	2025-05-26 09:15

ISSN	1948-0210 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Ophthalmology
Manuscript Type	Review
Article Title	Stem cell therapy for retinal pigment epithelium disorders
Manuscript Source	Invited Manuscript
All Author List	Francesco Saverio Sorrentino, Francesco Parmeggiani, Lorenzo Gardini, Luigi Fontana, Mutali Musa, Caterina Gagliano and Marco Zeppieri
ORCID	Author(s) ORCID Number Mutali Musa http://orcid.org/0000-0001-7486-8361 Caterina Gagliano http://orcid.org/0000-0001-8424-0068 Marco Zeppieri http://orcid.org/0000-0003-0999-5545
Funding Agency and Grant Number
Corresponding Author	Marco Zeppieri, MD, PhD, Department of Ophthalmology, University Hospital of Udine, p. le S. Maria della Misericordia 15, Udine 33100, Italy. mark.zeppieri@asufc.sanita.fvg.it
Key Words	Cell transplantation; Molecular stem cell mechanisms; Retinal degeneration; Stem cell therapy; Retinal pigment epithelium
Core Tip	There has been significant progress in research on the retinal pigment epithelium (RPE), with a particular focus on stem cell therapies and molecular discoveries that have the potential to treat retinopathies. The RPE is crucial for vision and the health of the eye. Studies have shown the potential of using stem cell-derived RPE to cure retinopathies in their early stages. Understanding the molecular and genetic mechanisms that are involved in the development and differentiation of RPE are fundamental when searching for novel therapeutic approaches.
Publish Date	2025-05-26 09:15
Citation	<p>Sorrentino FS, Parmeggiani F, Gardini L, Fontana L, Musa M, Gagliano C, Zeppieri M. Stem cell therapy for retinal pigment epithelium disorders. <i>World J Stem Cells</i> 2025; 17(5): 103100</p>
URL	https://www.wjgnet.com/1948-0210/full/v17/i5/103100.htm
DOI	https://dx.doi.org/10.4252/wjsc.v17.i5.103100

Full Article (PDF)	WJSC-17-103100-with-cover.pdf
Manuscript File	103100_Auto_Edited_065603.docx
Answering Reviewers	103100-answering-reviewers.pdf
Audio Core Tip	103100-audio.m4a
Conflict-of-Interest Disclosure Form	103100-conflict-of-interest-statement.pdf
Copyright License Agreement	103100-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	103100-non-native-speakers.pdf
Peer-review Report	103100-peer-reviews.pdf
Scientific Misconduct Check	103100-scientific-misconduct-check.png
Scientific Editor Work List	103100-scientific-editor-work-list.pdf
CrossCheck Report	103100-crosscheck-report.pdf